MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about SNY

Recent news which mentions SNY

< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
29 30 Next >
Fabry Disease Treatment Showdown: Protalix Bio's Elfabrio Joins the Ranks of Sanofi and Amicus Therapeutics
Tickers FOLD PLX SNY
Tags Briefs Health Care PLX
From Benzinga
7 Blue-Chip Stocks to Buy in May 2023
Tickers AMGN FRC JPM LMT
Tags TSM NYSE:LMT,NASDAQ:AMGN,NASDAQ:SNY,NYSE:VZ,NYSE:SHEL,NASDAQ:QCOM,NYSE:TSM,NYSE:FRC,NYSE:JPM Stocks to Buy
From InvestorPlace
Why Regeneron Pharmaceuticals Shares Are Trading Lower Today
Tickers REGN SNY
Tags News Biotech General
From Benzinga
7 Stock Upgrades and Downgrades Alerts You Cannot Ignore
Tickers ABBV INTC MSFT MXL
Tags NYSE:ABBV,NASDAQ:INTC,NASDAQ:MSFT,NASDAQ:MXL,NYSE:NET,NASDAQ:SNY,NASDAQ:TSCO NET MSFT
From InvestorPlace
First Republic Folds Amid Banking Crisis, Elon Musk Expects Starship To Make Orbit On Next Launch, DOJ Probes Mastercard Over Anti-Competitive Debit-Card Practices: Today's Top Stories
Tickers ADDYY ALPMY BLMN BNTX
Tags SPY Aerospace & Defense ADDYY
From Benzinga
European Union's Amended COVID-19 Vaccine Deal with Pfizer-BioNTech: Near-Monopoly Status Potential Threat to Rivals
Tickers BNTX MRNA NVAX PFE
Tags Health Care Large Cap BNTX
From Benzinga
Sanofi In-Licenses Pompe Disease Therapy From Privately-Held Maze Therapeutics For $150M Upfront
Tickers SNY
Tags Health Care Market News Contracts
From Benzinga
Sanofi (SNY) Q1 2023 Earnings Call Transcript
Tickers SNY
Tags Market News Recent Press Releases SNY
From Motley Fool
Sanofi Posts Upbeat Q1 Earnings, Sales Buoyed By Blockbuster Dupixent Sales
Tickers REGN SNY
Tags Health Care Market News Earnings
From Benzinga
Earnings Scheduled For April 27, 2023
Tickers OPRA ORC ORI OSK
Tags SAM ORC SLCA
From Benzinga
US Stocks Eye Higher Open As Meta Q1 Uplifts Tech Sector: Analyst Says 'No Earnings Recession In Cards Yet'
Tickers AAL ABBV AMGN AMZN
Tags News Previews AMZN
From Benzinga
Earnings Outlook For Sanofi
Tickers SNY
Tags Benzinga SNY Earnings
From Benzinga
Johnson & Johnson Unleashes Kenvue: Tylenol to Neutrogena, $40B Revenue Unit Spinoff Preps for IPO Blitz
Tickers BAYRY GSK HLN INTC
Tags Large Cap M&A BAYRY
From Benzinga
United Nations' Specialized Agency In Preliminary Talks With Takeda For Dengue Vaccine, Currently Under FDA Review
Tickers GSK MRK SNY TAK
Tags Benzinga SNY General
From Benzinga
Tiziana Life Sciences Has Only Fully Human Anti-CD3 mAB In Clinical Studies, Could Be Poised To Improve Care For Patients With Severe Multiple Sclerosis
Tickers EWTX IPHA PRVB SGEN
Tags Tiziana Life Sciences SGEN TBPH
From Benzinga
Cancer And Diabetes Remain Among The Deadliest And Most Debilitating Diseases — Is Gene Therapy The Solution? One Company, Genprex, Inc. (NASDAQ: GNPX), Thinks So
Tickers AMGN AZN BIIB BLUE
Tags BLUE Market News AMGN
From Benzinga
Treatments For Non-Active Secondary Progressive Multiple Sclerosis Remain Scarce – Tiziana Life Sciences' (NASDAQ: TLSA) First-In-Class Foralumab Is Showing Promise
Tickers PRVB SNY TLSA
Tags Partner Content SNY Tiziana Life Sciences
From Benzinga
Sanofi's $3B Acquisition Of Provention Bio Hits Regulatory Roadblock: FTC Requests More Information
Tickers PRVB SNY
Tags News Biotech General
From Benzinga
Hillstream BioPharma's Drug Candidate HSB-1216 Could Be One To Watch As Global Oncology Market Continues To Grow
Tickers BGNE BMY CRMD DD
Tags BGNE BMY JNJ
From Benzinga
Hillstream BioPharma's Drug Candidate HSB-1216 Could Be One To Watch As Global Oncology Market Continues To Grow
Tickers BGNE BMY CRMD DD
Tags GS Penny Stocks Market News
From Benzinga
2 Top Healthcare Stocks Defying the Bear Market
Tickers MCK SNY
Tags Recent Press Releases Market News MCK
From Motley Fool
Novo Nordisk Seeks to Solidify Its Lead in Diabetes Treatment and Crushing the Market
Tickers LLY MRK NVO SNY
Tags Market News Recent Press Releases MRK
From Motley Fool
Is This Pharma Duo on the Brink of Another Billion-Dollar Opportunity?
Tickers REGN SNY
Tags Recent Press Releases Market News REGN
From Motley Fool
Could This Label Expansion Be a Growth Catalyst for Sanofi Stock?
Tickers REGN SNY
Tags REGN Market News Recent Press Releases
From Motley Fool
Is Sanofi Stock a Buy Now?
Tickers PRVB SNY
Tags Recent Press Releases Market News SNY
From Motley Fool
Regeneron Pharmaceuticals Analysts React To Drug Trial Results: Why Whales Are Diving In
Tickers REGN SNY
Tags Raymond James Reiteration REGN
From Benzinga
Regeneron Pharmaceuticals Options Traders Betting On Stock Falling This Much By April Expiration
Tickers REGN SNY
Tags Market News Options Action CNBC
From Benzinga
Looking Into Sanofi's Recent Short Interest
Tickers SNY
Tags Trading Ideas SNY BZI/SHORTHIST
From Benzinga
Why Shares of Regeneron Are Rising Thursday
Tickers REGN SNY
Tags REGN Recent Press Releases Market News
From Motley Fool
REGN Stock Alert: Regeneron Pharmaceuticals Gains on Dupixent Drug Data
Tickers ACN COIN REGN SNY
Tags REGN NASDAQ:REGN,NASDAQ:SNY,NASDAQ:ZURA,NASDAQ:COIN,NYSE:ACN Today's Market
From InvestorPlace
< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
29 30 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story